Can You Use Metoclopramide If Breastfeeding?
Yes, metoclopramide can be safely used during breastfeeding and may actually increase milk supply, as it is also used as a galactagogue. 1
Guideline Recommendation
The 2020 Association of Anaesthetists guideline explicitly states that metoclopramide "may be used in lactating women" and notes that it is "also used as a galactagogue, so may increase milk supply." 1 This represents the most authoritative and recent guidance on this question, coming from a major professional society guideline published in the prestigious journal Anaesthesia.
FDA Labeling Considerations
The FDA label for metoclopramide provides a more cautious perspective, stating that "Metoclopramide is excreted in human milk. Caution should be exercised when metoclopramide is administered to a nursing mother." 2 The medication guide advises mothers to "talk with your doctor about the best way to feed your baby if you take metoclopramide" and notes that metoclopramide "is passed into human milk and may harm your baby." 2
However, this cautionary language must be interpreted in context: the FDA label does not contraindicate breastfeeding, but rather recommends discussion and monitoring—a standard approach for most medications during lactation.
Clinical Evidence on Efficacy and Safety
Milk Production Effects
Research evidence demonstrates that metoclopramide has galactagogue properties, though its efficacy is debated:
- In preterm mothers: A 2024 network meta-analysis found that metoclopramide did not significantly increase breast milk volume compared to placebo in mothers of preterm infants 3
- Overall effectiveness: A 2021 systematic review concluded that metoclopramide "did not improve milk production in lactating women" and recommended against using it specifically to increase milk production 4
- Historical data: An older 1983 study showed that metoclopramide increased total milk yield by approximately 50% during early puerperium compared to placebo 5
Safety Profile During Breastfeeding
The safety data is reassuring:
- Multiple systematic reviews found no significant adverse events in breastfeeding mothers or their infants when metoclopramide was used 3, 6, 4
- A 2021 meta-analysis showed no differences in maternal side effects between metoclopramide and placebo (RR = 1.05,95% CI [0.52 to 2.11]) 6
- A 2012 RCT comparing metoclopramide to domperidone found that 7 mothers taking metoclopramide reported side effects, though these were generally mild 7
Practical Clinical Approach
When prescribing metoclopramide to breastfeeding mothers:
- Inform the mother that metoclopramide passes into breast milk but is generally considered compatible with breastfeeding
- Use the lowest effective dose for the shortest duration needed (typically 10 mg three times daily)
- Monitor the infant for signs of drowsiness, irritability, or unusual behavior
- Limit duration to no more than 12 weeks due to tardive dyskinesia risk (though this applies to all patients, not specifically breastfeeding mothers) 2
- Consider the indication: If being used as a galactagogue specifically, be aware that evidence for efficacy is mixed and other options may be preferable
Important Caveats
Be aware of metoclopramide's serious risks (which apply to all patients, not just breastfeeding mothers):
- Tardive dyskinesia: Risk increases with duration of use and cumulative dose 2
- Extrapyramidal symptoms: More common in younger patients 2
- Depression and suicidality: Rare but serious neuropsychiatric effects 2
- Neuroleptic malignant syndrome: Very rare but potentially fatal 2
These risks should be weighed against the clinical indication for use, regardless of breastfeeding status.
Bottom Line
Metoclopramide is compatible with breastfeeding when clinically indicated for conditions like gastroparesis, nausea, or vomiting. The guideline evidence supports its use, and research shows no significant harm to breastfed infants. However, if the sole purpose is to increase milk supply, the evidence for efficacy is weak, and alternative galactagogues (like domperidone) may be preferable. Always use the lowest effective dose for the shortest necessary duration, and counsel mothers to monitor their infants for any unusual symptoms.